A non-ACE2-blocking neutralizing antibody against Omicron-included SARS-CoV-2 variants.
Duan X, Shi R, Liu P, Huang Q, Wang F, Chen X, Feng H, Huang W, Xiao J, Yan J.
Duan X, et al. Among authors: chen x.
Signal Transduct Target Ther. 2022 Jan 25;7(1):23. doi: 10.1038/s41392-022-00879-2.
Signal Transduct Target Ther. 2022.
PMID: 35078968
Free PMC article.
No abstract available.